1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. M11 Clinical Electronic Structured Harmonised Protocol
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

M11 Clinical Electronic Structured Harmonised Protocol May 2026

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-2022-D-3054
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research, Office of Regulatory Policy

The guidance includes three documents: a guidance, a template, and a technical specification document. The guidance provides the rationale and recommendations for implementing a harmonized digital clinical trial protocol. The template features standardized content structure and formatting, including headers and common text elements. The technical specification document contains harmonized terminologies and standardized data fields to enable electronic exchange of clinical protocol information. The intent of the guidance is to create an internationally harmonized standard for the content and exchange of clinical trial protocol information, facilitating the review and assessment by regulators, sponsors, ethical oversight bodies, investigators, and other stakeholders.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2022-D-3054.

Back to Top